Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

NDA accepted for antiinflammatory-antibiotic combination product

Nov. 7, 2003

AL-2512 as a potentially safer ocular antiinflammatory agent

Oct. 21, 2003

Visudyne approved in Japan for wet AMD

Oct. 20, 2003

Characterization of SU-10944, an orally active small-molecule inhibitor of VEGFR-2

Oct. 14, 2003

FDA accepts Vitrase NDA for filing

Oct. 10, 2003

Novartis presents new IOP-lowering agents in recent patent

Oct. 10, 2003

Improved vision observed in phase I/II trial of squalamine in wet AMD

Oct. 9, 2003

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

FDA accepts for filing diquafosol NDA for dry eye

Sep. 15, 2003

EntreMed grants Oxford BioMedica gene rights for ophthalmic applications

Sep. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...